General MedicationsINTRAVITREALStandard
IZERVAY
AVACINCAPTAD PEGOL SODIUM
Standard Dose
EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview IZERVAY is listed in Drugs@FDA under application 217225 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient AVACINCAPTAD PEGOL SODIUM Form and strength SOLUTION;INTRAVITREAL - EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) Sponsor ASTELLAS Submission history Latest submission status date: 2026-02-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview IZERVAY is listed in Drugs@FDA under application 217225 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient AVACINCAPTAD PEGOL SODIUM Form and strength SOLUTION;INTRAVITREAL - EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) Sponsor ASTELLAS Submission history Latest submission status date: 2026-02-27 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.